Skip to content

PHARMAPLUS ROCOURT

Active
Private limited companyfounded 1979active for 47 yearsChaussée de Tongres 431, 4000 Liège, BelgiumKBO/BCE: BE 0419.680.693

Directors

Directors
3 directors, last change in 2026

Board 3

GFB MANAGEMENT
Director (not named in the articles) · appointed in the act of 08-09-2026 · Private limited company · permanent representative: Roel Fiey
Current
PHARMA INVEST MANAGEMENT
Director (not named in the articles) · in office according to the act of 19-12-2023 · earlier manager, until 19-12-2023 · earlier director, until 01-04-2026 · term without a fixed end · Private limited company · permanent representative: PIRENNE Hubert · also on the board of 2 other companies
Current
VSF MANAGEMENT SRL
Director · appointed in the act of 22-05-2026 · earlier director (not named in the articles), until 08-09-2026 · Legal entity · permanent representative: Fiey Roel
Current
Permanent representatives 2
Roel Fiey
Permanent representative · appointed in the act of 08-09-2026 · for GFB MANAGEMENT
Current
PIRENNE Hubert
Permanent representative · in office according to the act of 19-12-2023 · for PHARMA INVEST MANAGEMENT
Current

Owners and capital

Shareholders

1 owner

Chain of control

  1. PHARMA INVEST MANAGEMENT 98%
  2. PHARMAPLUS ROCOURT

Owners 1

Capital transactions

Capital over time
  1. 19-12-2023 Converted to unavailable equity

Mandate history

3 people, 3 in office
Show
  • Board
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
PHARMA INVEST MANAGEMENT
  • Manager, until 19-12-2023
  • Director (not named in the articles), from before 19-12-2023 to 01-04-2026
  • Director (not named in the articles), since before 19-12-2023
VSF MANAGEMENT SRL
  • Director, appointed in the act of 22-05-2026, until 08-09-2026
  • Director, appointed in the act of 22-05-2026, still in office
GFB MANAGEMENT
  • Director (not named in the articles), appointed in the act of 08-09-2026, still in office

Articles of association

Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
“Un mois, commun accord ou défaut Président du Tribunal de l'Entreprise du siège”

Articles of association, deed of 19-12-2023 (in French)

Next steps